Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
J05AF09 Emtricitabine
D01199 Emtricitabine (JAN/USAN/INN) <US>
USP drug classification [BR:br08302]
Antivirals
Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTI)
Emtricitabine
D01199 Emtricitabine (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D01199 Emtricitabine (JAN/USAN/INN)
Drug groups [BR:br08330]
Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
D01199 Emtricitabine
DG01440 Arabinofuranosyl type antiviral
D01199 Emtricitabine
DG03107 Anti-HIV agent
DG01656 HIV reverse transcriptase inhibitor
D01199 Emtricitabine
Transporter substrate
DG02860 SLC22A8 substrate
D01199 Emtricitabine
Drug classes [BR:br08332]
Antiviral
DG03107 Anti-HIV agent
D01199 Emtricitabine
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HIV reverse transcriptase inhibitor
D01199 Emtricitabine (JAN/USAN/INN) <US>
Antimicrobials abbreviations [BR:br08327]
Antivirals
Genome replication inhibitor
HIV reverse transcriptase inhibitor
D01199 Emtricitabine (JAN/USAN/INN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D01199
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D01199
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01199
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01199
Drug metabolizing enzymes and transporters [br08309.html]
Drug transporters
D01199